Senior insider sale
Chief Operating Officer at RAPPORT THERAPEUTICS, INC. — senior position signals high conviction
$336.7K
12.01K shares
What this filing means
GAULT CHERYL plans to sell 12.01K shares of RAPPORT THERAPEUTICS, INC. valued at approximately $336.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/30/2026ACC: 0001950047-26-003074
Officer· Chief Operating Officer
Since Mar 2026
12.01K
Shares to sell
$336.7K
Approx. market value
10K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Founders Shares
N/A
9/5/2024
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/5/2024 | Founders Shares N/A | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.01K
Market value
$58.3K
3/5/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
10K
Market value
$278.4K
3/30/2026
Total
Units
12.01K
Value
$336.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/5/2026 | 2.01K | $58.3K | — | Completed |
| Planned — Approximate Date | ||||
3/30/2026 | 10K | $278.4K | NASDAQ | Planned |
| Total | 12.01K | $336.7K | ||